128 related articles for article (PubMed ID: 2552960)
1. The role of lipoproteins in EBV early antigen induction in Raji cells.
Simon M; Melzner I; Bültmann B
Arch Virol; 1989; 107(1-2):45-53. PubMed ID: 2552960
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of the cooperative effect between inducers of Epstein-Barr virus antigen synthesis.
Bauer G
J Gen Virol; 1983 Jun; 64 (Pt 6)():1337-46. PubMed ID: 6304236
[TBL] [Abstract][Full Text] [Related]
3. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
[TBL] [Abstract][Full Text] [Related]
4. Differential inducibility of Epstein-Barr virus in cloned, non-producer Raji cells.
Bister K; Yamamoto N; zur Hausen H
Int J Cancer; 1979 Jun; 23(6):818-25. PubMed ID: 89100
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells.
Boos H; Berger R; Kuklik-Roos C; Iftner T; Mueller-Lantzsch N
Virology; 1987 Jul; 159(1):161-5. PubMed ID: 3037776
[TBL] [Abstract][Full Text] [Related]
6. Steroids inhibit tumor promoting agent induced Epstein-Barr virus early antigens in Raji cells.
Sundar SK; Ablashi DV; Armstrong GR; Zipkin M; Faggioni A; Levine PH
Int J Cancer; 1981 Oct; 28(4):503-7. PubMed ID: 6273335
[TBL] [Abstract][Full Text] [Related]
7. Polyploidization of Epstein-Barr virus (EBV)-carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-1 virus superinfection or iododeoxyuridine treatment.
Shapiro IM; Andersson-Anvret M; Klein G
Intervirology; 1978; 10(2):94-101. PubMed ID: 209000
[TBL] [Abstract][Full Text] [Related]
8. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
Lidin BI; Lamon EW
Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934
[TBL] [Abstract][Full Text] [Related]
9. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate].
Furukawa M; Kato C; Kamide M; Umeda R
Nihon Jibiinkoka Gakkai Kaiho; 1989 Feb; 92(2):189-93. PubMed ID: 2545850
[TBL] [Abstract][Full Text] [Related]
10. Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle.
Klein G; Clements G; Zeuthen J; Westman A
Int J Cancer; 1976 Jun; 17(6):715-24. PubMed ID: 59708
[TBL] [Abstract][Full Text] [Related]
11. Chemically purified serum factor can induce both Epstein-Barr virus antigen synthesis and cell differentiation.
Anisimová E; Roubalová K; Bauer G; Roubal J
Arch Virol; 1987; 94(3-4):309-14. PubMed ID: 3034214
[TBL] [Abstract][Full Text] [Related]
12. Effect of indomethacin on Epstein-Barr virus early antigen induction.
Daniel LW; Bauer G; zur Hausen H
Cancer Res; 1984 Mar; 44(3):981-3. PubMed ID: 6318991
[TBL] [Abstract][Full Text] [Related]
13. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
Boguszaková L; Hirsch I; Brichácek B; Vonka V
J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
Yamamoto N; Mueller-Lantzsch N; zur Hausen H
Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of Epstein-Barr virus gene expression by other herpesviruses.
Kikuta H; Rapp F
Intervirology; 1988; 29(5):281-91. PubMed ID: 2848780
[TBL] [Abstract][Full Text] [Related]
17. Host cell regulation of induction of Epstein-Barr virus.
Glaser R; Nonoyama M
J Virol; 1974 Jul; 14(1):174-6. PubMed ID: 4365330
[TBL] [Abstract][Full Text] [Related]
18. Hybridization between a human epithelial line, infectable by Epstein-Barr virus, and Burkitt lymphoma lines: membrane properties, superinfectability, inducibility and tumorigenicity.
Mitrani-Rosenbaum S; Ber R; Goldblum N; Povey S; Gamliel H; Ben-Bassat H
Int J Cancer; 1982 Nov; 30(5):593-600. PubMed ID: 6295967
[TBL] [Abstract][Full Text] [Related]
19. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
Sairenji T; Nguyen QV; Woda B; Humphreys RE
J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic action of retinoic acid against teleocidin and 12-O-tetradecanoyl-phorbol-13-acetate on activation of Epstein-Barr virus genomes.
Lin JC; Smith MC
Carcinogenesis; 1984 Apr; 5(4):483-7. PubMed ID: 6323048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
